(Q39358604)

11 September 2017

Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugs (English)

1 reference

11 September 2017

1 reference

11

1 reference

11 September 2017

Ines Beyer

1

1 reference

11 September 2017

Hua Cao

2

1 reference

11 September 2017

Jonas Persson

3

1 reference

11 September 2017

Hui Song

4

1 reference

11 September 2017

Maximilian Richter

5

1 reference

11 September 2017

Qinghua Feng

6

1 reference

11 September 2017

Roma Yumul

7

1 reference

11 September 2017

Ruan van Rensburg

8

1 reference

11 September 2017

Zongyi Li

9

1 reference

11 September 2017

Ronald Berenson

10

1 reference

11 September 2017

Steve Roffler

12

1 reference

11 September 2017

Charles Drescher

13

1 reference

11 September 2017

André Lieber

14

1 reference

11 September 2017

language of work or name

English

0 references

publication date

24 April 2012

1 reference

11 September 2017

Clinical Cancer Research

1 reference

11 September 2017

18

1 reference

11 September 2017

12

1 reference

11 September 2017

3340-3351

1 reference

A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Epithelial-mesenchymal transition and tumour invasion

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Abnormal desmoglein expression by squamous cell carcinoma cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Mechanistic bases for differences in passive absorption.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547677

Expression of desmosomal proteins in squamous cell carcinomas of the skin

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22535153

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22535153

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-11-3213

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

22535153

1 reference